Header image

Session P: Oral Abstracts

Tracks
.
Friday, September 8, 2017
1:00 PM - 2:00 PM
Hudson I, II & III

Speaker

Attendee400

The Cost-Effectiveness Of Interventions To Improve Case Finding And Engagement With Hcv Treatment For People Who Inject Drugs In The UK

1:00 PM - 1:15 PM

Abstract

Biography

Attendee720

Hepatitis C Virus Phylogenetic Clustering And Latent Class Analysis Of Drug Use Among People Who Use Drugs In Vancouver Canada

1:15 PM - 1:30 PM

Abstract

Speaker Presentation

Biography

Attendee572

Collocation of HCV Treatment, Buprenorphine, and PrEP to Reduce Harm in PWID with HCV: Preliminary Data from the ANCHOR Study

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Biography

Attendee319

DAA TDaa Therapy For Hcv Infection Among People With A Substance Use History Attending An Inner-City Community Health Centre - Victoria, Canada

1:45 PM - 1:50 PM

Abstract

Speaker Presentation

Biography

Attendee737

Detachable Low Dead-Space Syringes For The Prevention Of Hepatitis C Among People Who Inject Drugs: An Economic Evaluation

1:50 PM - 1:55 PM

Abstract

Biography

Attendee696

Phylogenetic Clustering Among People With Recent Hepatitis C Virus Infection In Australia Between 2004-2015

1:55 PM - 2:00 PM

Abstract

Speaker Presentation

Biography

loading